The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States February 2021

Oliver, S., Gargano, J., Scobie, H., et al. (2021). The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. (Added 3/2/2021.) Morbidity and Mortality Weekly Report. 70(9):329-332.
This report documents the rationale supporting ACIP's interim recommendation to use the Johnson & Johnson/Janssen vaccine in persons age 18 and older.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.